Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01747486
Show Display Options
Rank Status Study
1 Completed CD19 Redirected Autologous T Cells
Condition: Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
Intervention: Biological: CART-19

Indicates status has not been verified in more than two years